Necessity for autologous blood storage and transfusion in patients undergoing pancreatoduodenectomy

Surgery Today

Volumn 47, Issue 5, 2017, Pages 568-574

  Tomimaru, Yoshito ^a   Noguchi, Kozo ^a   Dono, Keizo ^a  

^a TOYONAKA MUNICIPAL HOSPITAL   (Japan)

Author keywords

Autologous blood storage; Autologous blood transfusion; Pancreatoduodenectomy

Indexed keywords

HEMOGLOBIN;

AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD STORAGE; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREATICODUODENECTOMY; PATIENT SELECTION; PORTAL VEIN; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; SCORING SYSTEM; VEIN SURGERY; BLOOD; BLOOD SAMPLING; MIDDLE AGED; PANCREATIC NEOPLASMS; PREDICTIVE VALUE; PREOPERATIVE CARE; PROCEDURES; UTILIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; BLOOD TRANSFUSION, AUTOLOGOUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE;

EID: 84983486426     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-016-1407-4     Document Type: Article

References (34)

1. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch Pathol Lab Med. 1994;118:371–9.
2. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. First of two parts—blood transfusion. N Engl J Med. 1999;340:438–47.
3. Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.
4. Sutton JM, Kooby DA, Wilson GC, Squires MH 3rd, Hanseman DJ, Maithel SK, et al. Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg. 2014;18:1575–87.
5. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med. 1993;328:1372–6.
6. Bortul M, Calligaris L, Roseano M, Leggeri A. Blood transfusions and results after curative resection for gastric cancer. Suppl Tumori. 2003;2:S27–30.
7. Komatsu Y, Orita H, Sakurada M, Maekawa H, Hoppo T, Sato K. Intraoperative blood transfusion contributes to decreased long-term survival of patients with esophageal cancer. World J Surg. 2012;36:844–50.
8. Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, et al. Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol. 2011;17:3709–15.
9. Arima K, Hashimoto D, Okabe H, Inoue R, Kaida T, Higashi T, et al. Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer. Surg Today. 2016;46:792–7.
10. Mizuguchi T, Torigoe T, Satomi F, Shima H, Kutomi G, Ota S, et al. Trials of vaccines for pancreatic ductal adenocarcinoma: is there any hope of an improved prognosis? Surg Today. 2016;46:139–48.
11. Goodnough LT. Autologous blood donation. Crit Care. 2004;8(Suppl 2):S49–52.
12. Thomas MJ, Gillon J, Desmond MJ. Consensus conference on autologous transfusion. Preoperative autologous donation. Transfusion. 1996;36:633–9.
13. Cohen JA, Brecher ME. Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion. 1995;35:640–4.
14. Kasper SM, Ellering J, Stachwitz P, Lynch J, Grunenberg R, Buzello W. All adverse events in autologous blood donors with cardiac disease are not necessarily caused by blood donation. Transfusion. 1998;38:669–73.
15. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of two parts—blood conservation. N Engl J Med. 1999;340:525–33.
16. Tomimaru Y, Eguchi H, Wada H, Hama N, Kawamoto K, Kobayashi S, et al. Predicting the necessity of autologous blood collection and storage before surgery for hepatocellular carcinoma. J Surg Oncol. 2013;108:486–91.
17. Couvret C, Tricoche S, Baud A, Dabo B, Buchet S, Palud M, et al. The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty: the effect on subsequent transfusion rates. Anesth Analg. 2002;94:815–23 (table of contents).
18. Basran S, Frumento RJ, Cohen A, Lee S, Du Y, Nishanian E, et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg. 2006;103:15–20 (table of contents).
19. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229–39.
20. Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion. 1995;35:734–7.
21. Etchason J, Petz L, Keeler E, Calhoun L, Kleinman S, Snider C, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med. 1995;332:719–24.
22. Kruskall MS. Cost effectiveness of autologous blood donation. N Engl J Med. 1995;333:461–2 (author reply 3).
23. Brecher ME, Goodnough LT. The rise and fall of preoperative autologous blood donation. Transfusion. 2001;41:1459–62.
24. Vanderlinde ES, Heal JM, Blumberg N. Autologous transfusion. BMJ. 2002;324:772–5.
25. Carless P, Moxey A, O’Connell D, Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfus Med. 2004;14:123–44.
26. Heiss MM, Fasol-Merten K, Allgayer H, Strohlein MA, Tarabichi A, Wallner S, et al. Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. Vox Sang. 1997;73:237–45.
27. Sagawa K, Omokawa S, Furukawa Y. New guideline for autologous blood transfusion (in Japanese). J Jpn Soc Autologous Blood Transfus. 2007;20:10–34.
28. Japanese Ministry of Health LaW. Blood transfusion guideline (in Japanese). 3rd ed. Tokyo: Jiho Co; 2005.
29. Itamoto T, Katayama K, Nakahara H, Tashiro H, Asahara T. Autologous blood storage before hepatectomy for hepatocellular carcinoma with underlying liver disease. Br J Surg. 2003;90:23–8.
30. Pulitano C, Arru M, Bellio L, Rossini S, Ferla G, Aldrighetti L. A risk score for predicting perioperative blood transfusion in liver surgery. Br J Surg. 2007;94:860–5.
31. Lennox PA, Clugston PA, Beasley ME, Bostwick J 3rd. Autologous blood transfusion in TRAM breast reconstruction: is it necessary? Ann Plast Surg. 2004;53:532–5.
32. Vega SJ, Nguyen TV, Forsberg C, Hua LB, Kirkley SA, Herrera HR, et al. Efficacy of preoperative autologous blood donation in free TRAM flap breast reconstruction. Plast Reconstr Surg. 2008;121:241e–6e.
33. Billote DB, Abdoue AG, Wixson RL. Comparison of acute normovolemic hemodilution and preoperative autologous blood donation in clinical practice. J Clin Anesth. 2000;12:31–5.
34. Weber RS, Jabbour N, Martin RC 2nd. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol. 2008;15:34–45.